Ioannis Kopsidas
Overview
Explore the profile of Ioannis Kopsidas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Themistocleous S, Argyropoulos C, Vogazianos P, Shiamakkides G, Noula E, Nearchou A, et al.
JMIR Public Health Surveill
. 2024 Apr;
10():e47241.
PMID: 38573762
Background: The VACCELERATE Pan-European Scientific network aims to strengthen the foundation of vaccine trial research across Europe by following the principles of equity, inclusion, and diversity. The VACCELERATE Volunteer Registry...
2.
Maritsi D, Kopsidas I, Tsagkli P, Tsolia M
Rheumatology (Oxford)
. 2024 Mar;
63(SI2):SI270-SI272.
PMID: 38498836
No abstract available.
3.
Kopsidas I, Mentesidou L, Syggelou A, Papadimitriou M, Matsas M, Kossiva L, et al.
Rheumatol Int
. 2024 Mar;
44(12):3027-3033.
PMID: 38498151
Novel treatments have revolutionized the care and outcome of patients with juvenile idiopathic arthritis (JIA). Patients with rheumatic diseases are susceptible to infections, including vaccine preventable ones, due to waning...
4.
Mitsoura E, Kopsidas I, Charalambous P, Papazisis G, Raikos N, Pana Z
Antibiotics (Basel)
. 2024 Jan;
13(1).
PMID: 38247611
Background: Cyprus currently reports to ESAC-Net the total consumption of antimicrobials, without distinguishing between hospital and community-based antibiotic use. As a result, these data can only provide generalized insights into...
5.
Poulimeneas D, Koniordou M, Kousi D, Merakou C, Kopsidas I, Tsopela G, et al.
Vaccines (Basel)
. 2023 Dec;
11(12).
PMID: 38140188
Underserved and hard-to-reach population groups are under-represented in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation of these groups in member countries of the VACCELERATE...
6.
Karagiannidou S, Kopsidas I, Polemis M, Tryfinopoulou K, Zaoutis T
Euro Surveill
. 2023 Aug;
28(34).
PMID: 37616113
Antimicrobial resistance (AMR) in Greece is among the highest across the European Union/European Economic Area (EU/EEA), with high AMR rates even to last-line antibiotics. To better understand the clinical microbiology...
7.
Salmanton-Garcia J, Wipfler P, Valle-Simon P, Merakou C, Kopsidas I, Bethe U, et al.
Vaccine
. 2023 May;
41(26):3915-3922.
PMID: 37210309
Background: The inconsistent European vaccine trial landscape rendered the continent of limited interest for vaccine developers. The VACCELERATE consortium created a network of capable clinical trial sites throughout Europe. VACCELERATE...
8.
Kopsidas I, Dasoula F, Kourkouni E, Krepi A, Mystakelis H, Spyridis N, et al.
Eur J Pediatr
. 2023 May;
182(7):3293-3300.
PMID: 37160780
Conclusions: Several pediatricians in Greece use outdated and ineffective practices for the management of febrile seizures, despite the availability of updated evidence-based guidelines. Further training of practitioners is needed to...
9.
Kopsidas I, Kokkinidou L, Petsiou D, Kourkouni E, Triantafyllou C, Tsopela G, et al.
Antimicrob Steward Healthc Epidemiol
. 2023 Mar;
3(1):e40.
PMID: 36960086
Objective: To assess the effect of new legislation on the dispensing of antimicrobials without prescription from pharmacies in Greece. Design: In-person survey. Setting: The study included 110 pharmacies in the...
10.
Argyropoulos C, Leckler J, Salmanton-Garcia J, Constantinou M, Alexandrou A, Themistocleous S, et al.
JMIR Public Health Surveill
. 2023 Mar;
9:e44491.
PMID: 36878478
Background: The pan-European VACCELERATE network aims to implement the first transnational harmonized and sustainable vaccine trial Volunteer Registry, being a single entry point for potential volunteers of large-scale vaccine trials...